All Stories

  1. Population pharmacokinetics of apramycin from first-in-human plasma and urine data to support prediction of efficacious dose

    Article • Journal of Antimicrobial Chemotherapy, July 2022, Oxford University Press (OUP)

    Dr Staffan Rosenborg

  2. Mesalazine as a cause of fetal anemia and hydrops fetalis

    Article • Medicine, December 2017, Wolters Kluwer Health

    Dr Staffan Rosenborg

  3. High doses of anti-inflammatory drugs compromise muscle strength and hypertrophic adaptations to resistance training in young adults

    Article • Acta Physiologica, September 2017, Wiley

    Mats Lilja, Dr Staffan Rosenborg

  4. Experiences from using LC-MS/MS for analysis of immunosuppressive drugs in a TDM service

    Article • Clinical Biochemistry, September 2016, Elsevier

    Dr Staffan Rosenborg

  5. Ecological Effect of Solithromycin on Normal Human Oropharyngeal and Intestinal Microbiota

    Article • Antimicrobial Agents and Chemotherapy, May 2016, ASM Journals

    Prof Andrej Weintraub, Dr Staffan Rosenborg

  6. First report on the pharmacokinetics of tramadol and O-desmethyltramadol in exhaled breath compared to plasma and oral fluid after a single oral dose

    Article • Biochemical Pharmacology, December 2015, Elsevier

    Dr Staffan Rosenborg

  7. Ecological effect of ceftazidime/avibactam on the normal human intestinal microbiota

    Article • International Journal of Antimicrobial Agents, July 2015, Elsevier

    Dr Staffan Rosenborg

  8. Ecological Effect of Ceftaroline-Avibactam on the Normal Human Intestinal Microbiota

    Article • Antimicrobial Agents and Chemotherapy, May 2015, ASM Journals

    Dr Staffan Rosenborg

  9. Ecological Effect of Ceftaroline/Avibactam on the Normal Human Intestinal Microbiota

    Article • Open Forum Infectious Diseases, January 2015, Oxford University Press (OUP)

    Dr Staffan Rosenborg

  10. High Phenobarbital Clearance During Continuous Renal Replacement Therapy

    Article • Medicine, August 2014, Wolters Kluwer Health

    Dr Staffan Rosenborg

  11. Systematic conversion to generic tacrolimus in stable kidney transplant recipients

    Article • Clinical Kidney Journal, March 2014, Oxford University Press (OUP)

    Dr Staffan Rosenborg

  12. New potential cell source for hepatocyte transplantation: Discarded livers from metabolic disease liver transplants

    Article • Stem Cell Research, July 2013, Elsevier

    Dr Staffan Rosenborg

  13. Characteristics and apprehensions of clinical pharmacologists in Swedish healthcare—a questionnaire study

    Article • European Journal of Clinical Pharmacology, May 2013, Springer Science + Business Media

    Dr Staffan Rosenborg

  14. Quantification of Tacrolimus and Three Demethylated Metabolites in Human Whole Blood Using LC–ESI–MS/MS

    Article • Therapeutic Drug Monitoring, April 2012, Wolters Kluwer Health

    Dr Staffan Rosenborg

  15. Omeprazole limited sampling strategies to predict area under the concentration–time curve ratios: implications for cytochrome P450 2C19 and 3A phenotyping

    Article • European Journal of Clinical Pharmacology, October 2011, Springer Science + Business Media

    Dr Staffan Rosenborg

  16. Clinically Significant CYP2C Inhibition by Noscapine but Not by Glucosamine

    Article • Clinical Pharmacology & Therapeutics, July 2010, Nature

    Dr Staffan Rosenborg

  17. Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects

    Article • European Journal of Clinical Pharmacology, July 2008, Springer Science + Business Media

    Dr Staffan Rosenborg

  18. Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers

    Article • British Journal of Clinical Pharmacology, May 2008, Wiley

    Dr Staffan Rosenborg

  19. Noscapine may increase the effect of warfarin

    Article • British Journal of Clinical Pharmacology, February 2008, Wiley

    Dr Staffan Rosenborg

  20. Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3

    Article • Clinical Pharmacology & Therapeutics, March 2006, Nature

    Dr Staffan Rosenborg

  21. Persistent B19 parvovirus infection in pediatric malignancies

    Article • Medical and Pediatric Oncology, August 1998, Wiley

    Dr Staffan Rosenborg

  22. Persistent B19 parvovirus infection in pediatric malignancies

    Article • Medical and Pediatric Oncology, August 1998, Wiley

    Dr Staffan Rosenborg

  23. Immune Responses to the HIV rev Regulatory Gene

    Article • Karger Publishers

    Dr Staffan Rosenborg